Iron Knights with Nanosword Induced Ferroptosis in the Battle Against Oral Carcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39703040.
- Also identified by DOI 10.1021/acs.nanolett.4c05070.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oral squamous cell carcinoma (OSCC) is a tumor characterized by cellular redox imbalance, rendering it particularly sensitive to ferroptosis treatment. However, traditional ferroptosis inducers have a few drawbacks. In this study, ultrasmall AuMn nanoclusters (AMNCs) with a bovine serum albumin (BSA) ligand were synthesized and encapsulated in natural killer (NK) cell-derived exosomes to form an Exo-AMNCs composite for targeted ferroptosis therapy of OSCC. Unlike previously reported alloyed metal nanoclusters, not only do AMNCs react with intracellular H<sub>2</sub>O<sub>2</sub> to produce reactive oxygen species (ROS) and induce ferroptosis but also the BSA ligand improves biocompatibility and water solubility. These properties render AMNCs ideal for fluorescence imaging <i>in vivo</i>. When combined with NK cell exosomes, the Exo-AMNCs composite exhibited strong targeted imaging and therapeutic effects on OSCC. Further investigation into the mechanistic details demonstrated that Exo-AMNCs downregulate the overexpression of fat mass and obesity-associated (FTO) in OSCC and regulate the key ferroptosis-related protein glutathione peroxidase 4 (GPX4).
Medical subject headings
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
- Ferroptosis
- Gold
- Manganese
- Metal Nanoparticles
- Mouth Neoplasms
- Squamous Cell Carcinoma of Head and Neck